The Current and Evolving Role of PET in Personalized Management of Lung Cancer

Esther Mena1, Anusha Yanamadala1, Gang Cheng2

  • 1Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins School of Medicine, 601 North Caroline Street, Baltimore, MD 21287, USA.

PET Clinics
|June 21, 2016
PubMed

Insights

Genomic profiling transformed lung cancer treatment, guiding targeted therapies for mutations like EGFR and ALK. This review explores these genomic advances and their impact on positron emission tomography (PET) imaging for lung cancer.

Area of Science:

  • Oncology
  • Genetics
  • Radiology

Background:

  • Personalized treatment of lung cancer is increasingly driven by tumor genomic profiling.
  • Key discoveries include epidermal growth factor receptor (EGFR) mutations, anaplastic lymphoma kinase (ALK) fusions, and Kristen-Rat-Sarcoma (KRAS)/MET protooncogene alterations.
  • Positron emission tomography (PET) imaging is vital for assessing lung cancer biology and treatment response.

Purpose of the Study:

  • To review significant genomic discoveries in lung cancer.
  • To discuss the implications of these genomic findings for functional PET imaging.

Main Methods:

  • Literature review of genomic discoveries in lung cancer.
  • Analysis of the role of PET imaging in relation to these genomic alterations.

Main Results:

  • Genomic profiling has identified actionable targets, revolutionizing non-small cell lung cancer (NSCLC) treatment.
  • Targeted therapies (e.g., tyrosine kinase inhibitors) have emerged based on these discoveries.
  • PET imaging can reflect the biological behavior influenced by these genomic changes.

Conclusions:

  • Genomic discoveries are fundamentally changing lung cancer management.
  • Integrating genomic information with PET imaging offers new avenues for personalized therapy assessment and monitoring in lung cancer.

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
8.0K
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
611
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
721
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K